Zelluna ASA (OSL:ZLNA)
Norway · Delayed Price · Currency is NOK 15.65
-0.45 (-2.80%)
Nov 13, 2026, 4:25 PM CET
Zelluna ASA Revenue
Zelluna ASA had revenue of 226.00K NOK in the quarter ending September 30, 2026. This brings the company's total for the last twelve months to 386.00K, up 628.30% year-over-year. That makes Zelluna ASA the 46,668th largest company in the world by revenue and 256th in Norway.
Revenue (ttm)
386.00K
Revenue Growth
+628.30%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
15
Market Cap
467.32M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 53.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 13.30M | 175.00K | 1.33% |
| Dec 31, 2021 | 13.13M | 704.38K | 5.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ArcticZymes Technologies ASA | 136.70M |
| Arctic Bioscience AS | 48.96M |
| Oncoinvent ASA | 24.31M |
| SoftOx Solutions AS | 13.88M |
| Aqua Bio Technology ASA | 5.67M |
| Nykode Therapeutics AS | 4.60M |
| Thor Medical ASA | 1.64M |
| Lytix Biopharma ASA | 377.00K |
Zelluna ASA News
- 9 days ago - Zelluna ASA Earnings Call Transcript: Q3 2026 - Transcripts
- 9 days ago - Zelluna ASA Slides: Q3 2026 - Filings
- 9 days ago - Zelluna ASA Quarterly report: Q3 2026 - Filings
- 10 days ago - Zelluna ASA Transcript: BioStock Life Science Summit 2026 - Transcripts
- 2 months ago - Zelluna Reports Q2 2026 Results, Advances First-in-Human TCR-NK Trial - Nasdaq
- 2 months ago - Zelluna ASA Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Zelluna ASA Quarterly report: Q2 2026 - Filings
- 2 months ago - Zelluna ASA Slides: Q2 2026 - Filings